Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting

Back to Jobs

Preclinical results to be presented for GJB2 gene therapy hearing loss collaboration and OTO-510 program for cisplatin otoprotection SAN DIEGO , Jan. 23, 2020 (GLOBE NEWSWIRE) — Otonomy , Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for

Apply Now